{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:33:28Z","timestamp":1794483208341,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX25_0786"],"award-info":[{"award-number":["SJCX25_0786"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX25_0795"],"award-info":[{"award-number":["SJCX25_0795"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Health Commission","doi-asserted-by":"publisher","award":["K2024057"],"award-info":[{"award-number":["K2024057"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.isci.2026.117780","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:55:03Z","timestamp":1791449703000},"page":"117780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic polymorphisms and early responses predict refractory hyperthyroidism during antithyroid drug therapy"],"prefix":"10.1016","volume":"29","author":[{"given":"Xinpan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6375-3622","authenticated-orcid":false,"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-4922","authenticated-orcid":false,"given":"Xuqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117780_bib1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(23)02016-0","article-title":"Hyperthyroidism","volume":"403","author":"Chaker","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117780_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ecl.2021.12.004","article-title":"2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease","volume":"51","author":"Hoang","year":"2022","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.isci.2026.117780_bib3","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1210\/clinem\/dgae222","article-title":"A 2023 International Survey of Clinical Practice Patterns in the Management of Graves Disease: A Decade of Change","volume":"109","author":"Villagelin","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.117780_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12967-024-05129-3","article-title":"Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.117780_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5603\/ep.99555","article-title":"Block-and-replace regimen versus titration of antithyroid drugs: a recent meta-analysis","volume":"75","author":"Stancu","year":"2024","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.isci.2026.117780_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41574-024-01016-5","article-title":"Graves disease: latest understanding of pathogenesis and treatment options","volume":"20","author":"Lanzolla","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.isci.2026.117780_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/17446651.2020.1754192","article-title":"Current controversies in the management of Graves' hyperthyroidism","volume":"15","author":"Francis","year":"2020","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.117780_bib8","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-25-0039","article-title":"High-dose versus low-dose block-and-replace treatment for a first episode of Graves' disease","volume":"14","author":"Smolders","year":"2025","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.isci.2026.117780_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411823","article-title":"Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications","volume":"26","author":"Xiao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117780_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1561455","article-title":"Exploring antigenic variation in autoimmune endocrinopathy","volume":"16","author":"Mavridou","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117780_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112313","article-title":"Unraveling susceptibility genes: A contemporary overview of autoimmune thyroid diseases","volume":"136","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.117780_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11154-023-09848-8","article-title":"The genetics of Graves' disease","volume":"25","author":"Grixti","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.isci.2026.117780_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.691781","article-title":"Precision Medicine in Graves' Disease: CD40 Gene Variants Predict Clinical Response to an Anti-CD40 Monoclonal Antibody","volume":"12","author":"Faustino","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.117780_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.761077","article-title":"Recurrence of Graves' Disease: What Genetics of HLA and PTPN22 Can Tell Us","volume":"12","author":"Vejrazkova","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.117780_bib15","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s40618-024-02358-7","article-title":"The need for the GREAT+ score to predict relapse in Graves' disease: a questionnaire among patients and internal medicine specialists","volume":"47","author":"Jansen","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.isci.2026.117780_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11154-016-9386-8","article-title":"Relapse prediction in Graves' disease: Towards mathematical modeling of clinical, immune and genetic markers","volume":"17","author":"Langenstein","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.isci.2026.117780_bib17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.117780_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.898","article-title":"A genome-wide association study identifies two new risk loci for Graves' disease","volume":"43","author":"Chu","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.117780_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41588-020-0640-3","article-title":"Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases","volume":"52","author":"Ishigaki","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.117780_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.759597","article-title":"Compelling Evidence Linking CD40 Gene With Graves' Disease in the Chinese Han Population","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.117780_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.isci.2026.117780_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1089\/thy.2020.0715","article-title":"Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis","volume":"31","author":"Scappaticcio","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.isci.2026.117780_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12020-025-04372-y","article-title":"Antithyroid drugs and the dose-risk balance: a meta-analysis on agranulocytosis in hyperthyroidism","volume":"90","author":"Ram\u00edrez Stieben","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.isci.2026.117780_bib24","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1210\/jc.2015-3644","article-title":"Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism","volume":"101","author":"Vos","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.117780_bib25","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s40618-018-0918-9","article-title":"Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management","volume":"41","author":"Masiello","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.isci.2026.117780_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eprac.2024.12.011","article-title":"A Predictive Model for Graves' Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study. Endocrine practice","volume":"31","author":"El Kawkgi","year":"2025","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.isci.2026.117780_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/clinem\/dgad538","article-title":"Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy","volume":"109","author":"Meling Stokland","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.117780_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.eprac.2024.12.012","article-title":"Management Aspects of Medical Therapy in Graves Disease. Endocrine practice","volume":"31","author":"Shah","year":"2025","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.isci.2026.117780_bib29","doi-asserted-by":"crossref","first-page":"e3002","DOI":"10.1210\/clinem\/dgae892","article-title":"Significance of Thyroid-Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves Disease","volume":"110","author":"Peng","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.117780_bib30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1089\/thy.2020.0756","article-title":"Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease","volume":"31","author":"Kim","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.isci.2026.117780_bib31","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s40618-023-02044-0","article-title":"In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features","volume":"46","author":"Brancatella","year":"2023","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.isci.2026.117780_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biochi.2019.02.003","article-title":"Thyroid peroxidase as a dual active site enzyme: Focus on biosynthesis, hormonogenesis and thyroid disorders of autoimmunity and cancer","volume":"160","author":"Godlewska","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.isci.2026.117780_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12020-020-02337-x","article-title":"Polymorphisms of the genes CTLA4, PTPN22, CD40, and PPARG and their roles in Graves' disease: susceptibility and clinical features","volume":"71","author":"Bufalo","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.isci.2026.117780_bib34","article-title":"Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves' Disease and Hashimoto's Hypothyroidism","volume":"105","author":"Zhang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.117780_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.842673","article-title":"Analysis of HLA Variants and Graves' Disease and Its Comorbidities Using a High Resolution Imputation System to Examine Electronic Medical Health Records","volume":"13","author":"Liao","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.117780_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002961","article-title":"VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy","volume":"23","author":"Jiang","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.isci.2026.117780_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells12182315","article-title":"Characterisation of Lipoma-Preferred Partner as a Novel Mechanotransducer in Vascular Smooth Muscle Cells","volume":"12","author":"Sporkova","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117780_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1089\/thy.2019.0180","article-title":"Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial","volume":"29","author":"Azizi","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.isci.2026.117780_bib39","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0226","article-title":"Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort","volume":"12","author":"Jin","year":"2023","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.isci.2026.117780_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cca.2008.11.025","article-title":"Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies","volume":"401","author":"Hermsen","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2026.117780_bib41","article-title":"Recent advances of trace elements in autoimmune thyroid disease","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117780_bib42","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0406","article-title":"The impact of autoimmune thyroid disease on cognitive and psychiatric disorders: focus on clinical, pre-clinical and molecular studies","volume":"14","author":"Piekie\u0142ko-Witkowska","year":"2025","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.isci.2026.117780_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103955","article-title":"Environmental toxins and toxic metals in autoimmune diseases: Sex differences, hormonal influences, and immune dysregulation","volume":"25","author":"Bj\u00f8rklund","year":"2026","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.117780_bib44","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1055\/s-2008-1070506","article-title":"[Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl)]","volume":"106","author":"Brunn","year":"1981","journal-title":"Dtsch. Med. Wochenschr."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:37:11Z","timestamp":1794479831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226031615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589004226031615"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117780","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic polymorphisms and early responses predict refractory hyperthyroidism during antithyroid drug therapy","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117780"}}